Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 31, 2026
CWEB +25% Surge Over 30 Days: What Powered the China Internet Leveraged ETF Recovery

CWEB +25% Surge Over 30 Days: What Powered the China Internet Leveraged ETF Recovery

Key Takeaways

  • CWEB surged approximately 25% over the past 30 days, propelled by a sharp recovery in Chinese internet stocks after a deep sell-off in May and June.
  • Over the last quarter, the ETF remains down roughly 7%, reflecting the volatile, V-shaped trajectory that characterized the broader China internet sector during this period.
  • The primary catalyst was the regulatory approval of Apple Intelligence in China, which will use BABA's Qwen AI model — igniting a broad re-rating of Chinese technology companies.
  • Record-breaking capital inflows into China-focused equity funds and accelerating southbound flows into Hong Kong provided powerful tailwinds.
  • As a 2x leveraged fund, CWEB amplified both the June drawdown and the July recovery, underscoring the elevated risk-and-reward profile inherent to leveraged ETF strategies.

CWEB Overview and Portfolio Exposure

CWEB is a leveraged ETF that seeks to deliver 200% of the daily performance of the CSI Overseas China Internet Index. The underlying index tracks publicly traded China-based companies focused on internet and internet-related sectors. Launched in November 2016 and managed by Direxion, the fund holds roughly $230 million to $240 million in assets under management with a net expense ratio of about 1.25% to 1.27%.

The fund gains its leveraged exposure mainly through holdings in the KraneShares CSI China Internet ETF (KWEB), which makes up roughly 56% to 66% of net assets, along with swaps and cash collateral. Through KWEB, CWEB's exposure concentrates in Communication Services (around 45%) and Consumer Cyclical (about 35%), with smaller weights in Healthcare, Technology, and Real Estate. Top underlying holdings include Tencent Holdings, BABA, PDD Holdings, Meituan, NetEase, Baidu, JD.com, and Kuaishou. This concentrated, high-beta setup makes CWEB particularly sensitive to shifts in Chinese internet sentiment, which explains the scale of its recent move.

CWEB Price Performance: Last 30 Days Versus the Quarter

Over the past 30 days, CWEB rose roughly 25%, moving from a July 1 close of $19.93 to around $24.84 in late-July trading. The advance was not smooth, with notable spikes in mid-July after the Apple Intelligence approval sparked a rally in US-listed Chinese internet shares. Volume in strong sessions topped 1.3 million shares, well above the fund's typical 500,000 to 600,000 shares.

Over the full quarter, however, CWEB is still down about 7%. It began May near $26.50 to $28.50 before a sharp seven-week drop that bottomed at $17.70 on June 25. That created a roughly 40% trough-to-peak swing within the quarter. The V-shaped pattern highlights how the 2x daily structure amplifies both losses and gains.

What Drove the 30-Day Advance

The standout catalyst came when China's cyberspace regulator approved Apple Intelligence for iPhones in the country, ending a two-year wait. BABA confirmed its Qwen AI model would integrate into Apple's iOS, iPadOS, and macOS platforms in China, while BIDU was also named a partner. BABA shares jumped as much as 27% in July, becoming the largest single contributor to CWEB's performance.

Broader AI momentum added fuel. Tencent noted its Hunyuan Hy3 model saw usage grow more than 68-fold from the prior version and briefly ranked first globally on OpenRouter. Xiaomi's MiMo-V2.5 model led OpenRouter's weekly and monthly rankings at the same time. Meituan open-sourced LongCat-2.0, and Alibaba's cloud revenue was expected to grow around 45% year-over-year, beating earlier forecasts.

Capital flows reinforced the move. China-focused equity funds pulled in $9 billion in one early-July week, the largest inflow since December 2025 per BofA Global Research. Southbound flows into Hong Kong via Stock Connect reached about HK$873 billion in July, far above the HK$271 billion seen in all of June. The People's Bank of China also signaled support by pledging higher foreign-exchange reserve allocations to Hong Kong.

US macro conditions helped as well. The June PCE price index fell 0.1% month-over-month, the first decline in six years, while core PCE rose just 0.1%, below expectations. Softer inflation eased rate-hike concerns and supported growth equities, including emerging-market tech names. The subsequent MSFT rally after strong earnings, with Azure revenue up 43%, further lifted global cloud and AI sentiment.

Quarterly Drawdown Context

The quarterly decline of roughly 7% understates the severity of the May-June drop. The MSCI China Index neared bear-market territory, falling more than 20% from its October 2025 peak. Chinese retail sales contracted in May for the first time since the pandemic, and consumer spending during the Dragon Boat Festival was flat year-over-year. The "618" shopping event saw muted demand, and Beijing's regulator reprimanded major e-commerce platforms including BABA, JD, and PDD Holdings over promotional practices.

Index composition also weighed on offshore Chinese equities. Unlike South Korean and Taiwanese benchmarks heavy in semiconductors benefiting from the global AI cycle, offshore China indices remain dominated by internet platforms and consumer businesses. Global capital rotated toward pure-play AI hardware, leaving Chinese internet stocks underowned. Analysts cut forward earnings estimates for Hang Seng China Enterprises Index constituents by nearly 3% while raising projections for Korea's Kospi by 246% and Taiwan's Taiex by 58%.

Weak domestic consumption, geopolitical tensions including the Pentagon adding BABA and BYD to a list of companies allegedly working with the Chinese government, and the rotation away from internet platforms created a difficult backdrop that CWEB's 2x structure magnified.

Outlook for CWEB: Key Factors to Monitor

Whether the July rebound holds will depend on whether the AI-driven re-rating of Chinese internet stocks moves beyond short-term sentiment into lasting fundamental gains. August earnings from BABA, Tencent, Meituan, JD.com, and Baidu will provide the next test, with focus on cloud growth, AI monetization, e-commerce margins, and capex guidance.

China's macro picture stays fragile. The property market showed tentative stabilization in June with slower new-home price declines, yet excess supply and years of falling prices continue to pressure household wealth and confidence. The State Council's five-year consumption plan targeting 60 trillion yuan in retail sales by 2030 offers a framework, but details on timing remain limited. Any major new fiscal or monetary stimulus from the Politburo could act as a catalyst.

US policy and the dollar will also influence flows into emerging-market equities. Cooling US inflation has helped, but any reacceleration could shift rate-cut expectations. Geopolitical developments around US-China trade and technology policy remain ongoing risks.

Investors should keep in mind the mechanics of leveraged ETFs. CWEB's 2x daily reset means returns over periods longer than one day can diverge from twice the index return, especially in volatile markets where compounding matters. The fund's expense ratio and roughly 81% portfolio turnover add further considerations. The recent rally shows the upside leverage can deliver when sentiment turns positive, but the same structure can accelerate losses when conditions change.

Using Tickeron’s AI Screener in My Research

In my research, I frequently turn to Tickeron’s AI Screener to scan volatile sectors like Chinese internet equities. It helps me apply technical indicators, fundamental metrics, volatility measures, and AI signals across thousands of securities to spot trends and compare opportunities more efficiently than manual methods alone. This tool has become a regular part of how I evaluate leveraged ETFs and their underlying drivers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CWEB

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


CWEB in upward trend: price rose above 50-day moving average on July 27, 2026

CWEB moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 27, 2026. You may want to consider a long position or call options on CWEB as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CWEB just turned positive on July 01, 2026. Looking at past instances where CWEB's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CWEB crossed bullishly above the 50-day moving average on July 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CWEB advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 166 cases where CWEB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CWEB moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CWEB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CWEB broke above its upper Bollinger Band on July 31, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily investment results, of 200% of the daily performance of the CSI Overseas China Internet Index. The index is designed to measure the performance of the investable universe of publicly traded China-based companies whose primary business or businesses are in the Internet and Internet-related sectors. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. It is non-diversified.
View a ticker or compare two or three
CWEB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.